SOLIS MINERALS LTD. (ASX:SLM) Reports Financial Results for Six Months Ended November 30, 2024
SOLIS MINERALS LTD. (ASX:SLM) reports a loss of $2.22M for the six months ending November 30, 2024, as the company refines its exploration strategy.
Category: Healthcare
Anteris Technologies Global Corp. (ASX:AVR) Announces Over-Allotment Exercise
Anteris Technologies (ASX:AVR) reports partial over-allotment option exercise and the conclusion of the stabilisation period following its U.S. IPO.
Compumedics Limited (ASX:CMP) Reports Record H1 FY25 Sales
Compumedics Limited (ASX:CMP) announces record sales orders of $32.8 million for H1 FY25, up 55% year-on-year.
Nanoveu Limited (ASX: NVU) Unveils ECS-Dot Chipset for Fall Detection
Nanoveu Limited’s ECS-Dot Chipset demonstrates leading energy-efficient fall detection technology, with plans for further assessments and partnerships.
Orthocell Limited (ASX:OCC) Announces Record Revenue and Market Expansion
Orthocell (ASX:OCC) reports record revenue and strategic market expansion in its latest quarterly update.
HITIQ Limited (ASX: HIQ) Reports R&D Tax Incentive Receipt
HITIQ Limited (ASX: HIQ) announces $1.6 million R&D Tax Incentive receipt and related repayment updates.
First Graphene Limited (ASX:FGR) Responds to ASX Price Query
First Graphene Limited (ASX:FGR) addresses ASX concerns regarding price movements and highlights its ongoing commercial developments.
Immuron Limited (ASX:IMC) Announces Travelan® Clinical Trial Update
Immuron Limited announces positive Phase 2 results for Travelan®, with FDA submission pending and strong immunology findings.
Matrix Composites & Engineering Ltd (ASX:MCE) Secures Major Contract
Matrix Composites secures a $7M contract from Stena Drilling for Deepwater Drilling Riser Buoyancy Systems, strengthening its market position.
Mesoblast Limited (ASX:MSB) Completes A$260 Million Capital Raise
Mesoblast Limited raises A$260M to fund the launch of Ryoncil and expand clinical development.